Publications Advancy

Advancy acted as a strategic co-advisor for Carlyle in the €10.1bn acquisition of AkzoNobel Specialty Chemicals

By 29 mai 2018 No Comments

Advancy acted as a strategic co-advisor for Carlyle in the €10.1bn acquisition of AkzoNobel Specialty Chemicals

29 mai 2018 | Publications Advancy
  • In March 2018, Carlyle, the US private equity group, won the competitive auction to acquire
    100% of AkzoNobel Specialty Chemicals.
  • The deal is to be completed before the end of 2018
  • The transaction represents:
    – The largest-ever chemicals LBO globally, after Axalta acquisition by Carlyle for $4.9bn in August 2012
    –  The largest European LBO in the last 10 years
  • Advancy acted as a strategic co-advisor for Carlyle